Relative and absolute bioavailability study of emicizumab to bridge drug products and subcutaneous injection sites in healthy volunteers - Kotani, N; Yoneyama, K; Kawakami, N; Shimuta, T; Fukase, H; Kawanishi, T (Clin Pharmacol Drug Dev, 2019)